Literature DB >> 1871040

Molecular structure and dynamics of cis(Z)-and trans(E)-flupenthixol and clopenthixol.

I Sylte1, S G Dahl.   

Abstract

The three-dimensional structures and molecular electrostatic potentials of the cis(Z) and trans(E)-isomers of flupenthixol and clopenthixol were examined by computer graphics and molecular mechanical and quantum mechanical calculations, and their internal molecular motions were studied by molecular dynamics simulations in vacuo and in aqueous solution. The simulations demonstrated that both the side chains and the tricyclic ring systems of clopenthixol and flupenthixol are highly flexible. The angle between the two phenyl ring planes varied between 105 and 171 degrees during the simulations in solution. The electrostatic potentials around the 2-substituent were significantly more negative in the trans(E)-isomers than in the cis(Z)-isomers. The stronger negative potentials may weaken electrostatic receptor interactions and, thereby, cause the trans(E)-isomers to be less active than cis(Z)-isomers. Differences both in three-dimensional structure and in electronic structure may cause the difference in pharmacological activity between cis(Z)- and trans(E)-thioxanthenes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871040     DOI: 10.1023/a:1015842926345

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Drug design via pharmacophore identification. Dopaminergic activity of 3H-benz[e]indol-8-amines and their mode of interaction with the dopamine receptor.

Authors:  A A Asselin; L G Humber; K Voith; G Metcalf
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

2.  Conformation of acetylcholine bound to the nicotinic acetylcholine receptor.

Authors:  R W Behling; T Yamane; G Navon; L W Jelinski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  The structure of the catecholamines. II. The crystal structure of dopamine hydrochloride.

Authors:  R Bergin; D Carlström
Journal:  Acta Crystallogr B       Date:  1968-11-15       Impact factor: 2.266

4.  A three dimensional receptor model of the dopamine D2 receptor from computer graphic analyses of D2 agonists.

Authors:  D T Manallack; P M Beart
Journal:  J Pharm Pharmacol       Date:  1988-06       Impact factor: 3.765

Review 5.  Dynamics of proteins: elements and function.

Authors:  M Karplus; J A McCammon
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Solvent-accessible surfaces of proteins and nucleic acids.

Authors:  M L Connolly
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

7.  Three-dimensional structure and molecular dynamics of cis(Z)- and trans(E)-chlorprothixene.

Authors:  I Sylte; S G Dahl
Journal:  J Pharm Sci       Date:  1991-08       Impact factor: 3.534

8.  Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.

Authors:  J Hyttel; J Arnt
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Dopamine D2 receptor binding sites for agonists. A tetrahedral model.

Authors:  P Seeman; M Watanabe; D Grigoriadis; J L Tedesco; S R George; U Svensson; J L Nilsson; J L Neumeyer
Journal:  Mol Pharmacol       Date:  1985-11       Impact factor: 4.436

10.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  2 in total

1.  Flupentixol: relevance of stereoselective therapeutic drug monitoring.

Authors:  Pierre Baumann; Hartmut Kirchherr; Patricia Berney; Christoph Hiemke
Journal:  Psychopharmacology (Berl)       Date:  2012-04-04       Impact factor: 4.530

2.  Structural changes by sulfoxidation of phenothiazine drugs.

Authors:  S G Dahl; P A Kollman; S N Rao; U C Singh
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.